Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $339,227 - $407,253
-30,100 Reduced 14.99%
170,700 $2.04 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $1.76 Million - $2.18 Million
200,800 New
200,800 $2.17 Million
Q1 2023

May 12, 2023

SELL
$9.2 - $12.26 $276,000 - $367,800
-30,000 Reduced 46.15%
35,000 $336,000
Q4 2022

Feb 10, 2023

BUY
$8.72 - $11.56 $566,800 - $751,400
65,000 New
65,000 $723,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.